Raltegravir Potassium

Spezifikationen

871038-72-1CAS-Nummer

682-461-3EG-Nummer

potassium 4-[(4-fluorophenyl)methylcarbamoyl]-1-methyl-2-[2-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]propan-2-yl]-6-oxopyrimidin-5-olateIUPAC-Name

C20H20FKN6O5Chemische Formel

482.5 g/molMolekulargewicht

Raltegravir potassium; 871038-72-1; Raltegravir Potassium Salt; Isentress; MK0518 POTASSIUM; MK-0518 POTASSIUM; Raltegravir monopotassium salt; 43Y000U234; Isentress hd; L000900612 POTASSIUM SALT; L-000900612 POTASSIUM SALT; DUTREBIS COMPONENT RALTEGRAVIR POTASSIUM; N-((4-Fluorophenyl)methyl)-1,6-dihydro-5-hydroxy-1-methyl-2-(1-methyl-1-(((5-methyl-1,3,4-oxadiazol-2-yl)carbonyl)amino)ethyl)-6-oxo-4-pyrimidinecarboxamide monopotassium salt; Potassium, Raltegravir; RefChem:55965; potassium 4-((4-fluorobenzyl)carbamoyl)-1-methyl-2-(2-(5-methyl-1,3,4-oxadiazole-2-carboxamido)propan-2-yl)-6-oxo-1,6-dihydropyrimidin-5-olate; MFCD12031642; Raltegravir (potassium); Raltegravir (potassium salt); Raltegravir ( K salt) API; C20H20FKN6O5; 4-Pyrimidinecarboxamide, N-((4-fluorophenyl)methyl)-1,6-dihydro-5-hydroxy-1-methyl-2-(1-methyl-1-(((5-methyl-1,3,4-oxadiazol-2-yl)carbonyl)amino)ethyl)-6-oxo-, monopotassium salt; Raltegravir potassium [USAN]; Isentress (TN); Raltegravir potassium [USAN:JAN]; UNII-43Y000U234; 871038-72-1 (potassium); Potassium 4-((4-fluorobenzyl)carbamoyl)-1-methyl-2-(1-methyl-1-(((5-methyl-1,3,4-oxadiazol-2-yl)carbonyl)amino)ethyl)-6-oxo-1,6-dihydropyrimidin-5-olate; Potassium 4-[(4-fluorobenzyl)carbamoyl]-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-1,6-dihydropyrimidin-5-olate; Raltegravir potassium CRS; MK-0518 potassium salt; potassium;4-[(4-fluorophenyl)methylcarbamoyl]-1-methyl-2-[2-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]propan-2-yl]-6-oxopyrimidin-5-olate; CHEMBL518520; orb1223793; orb1305955; SCHEMBL15939218; IFUKBHBISRAZTF-UHFFFAOYSA-M; DTXSID501007339; GLXC-90403; HMS5084D19; HY-10353AR; Raltegravir potassium (JAN/USAN); RALTEGRAVIR POTASSIUM [JAN]; Raltegravir (potassium) (Standard); L000900612 POTASSIUM; HY-10353A; MK-518; s5245; L-000900612 POTASSIUM; RALTEGRAVIR POTASSIUM [MART.]; AKOS015896594; RALTEGRAVIR POTASSIUM [USP-RS]; RALTEGRAVIR POTASSIUM [WHO-DD]; AC-2062; CCG-269568; CS-3263; FR27670; Raltegravir for peak identification CRS; AS-19171; BR164314; Raltegravir potassium - Bio-X trade mark; SY258338; RALTEGRAVIR MONOPOTASSIUM SALT [MI]; RALTEGRAVIR POTASSIUM [ORANGE BOOK]; RALTEGRAVIR POTASSIUM [EP MONOGRAPH]; RALTEGRAVIR POTASSIUM [USP MONOGRAPH]; D07133; AB01274746-01; F792626; Q27258678; 4-Pyrimidinecarboxamide, N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-, potassium salt(1:1); N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo -4-pyrimidinecarboxamide potassium salt; Potassium 4-[{[(4-fluorophenyl)methyl]imino}(hydroxy)methyl]-1-methyl-2-[2-(5-methyl-1,3,4-oxadiazole-2-carboxamido)propan-2-yl]-6-oxo-1,6-dihydropyrimidin-5-olate; Potassium 4-[{[(4-fluorophenyl)methyl]imino}(hydroxy)methyl]-1-methyl-2-{2-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]propan-2-yl}-6-oxo-1,6-dihydropyrimidin-5-olate; potassium 4-{[(4-fluorophenyl)methyl]carbamoyl}-1-methyl-2-{2-[(5-methyl-1,3,4-oxadiazol-2-yl)formamido]propan-2-yl}-6-oxo-1,6-dihydropyrimidin-5-olate; potassium;4-[(4-fluorophenyl)methylcarbamoyl]-1-methyl-2-[1-methyl-1-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]ethyl]-6-oxo-pyrimidin-5-olate; Raltegravir Potassium MicronizedSynonyme